跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 14,320 条关于
“Forbes Tate Partners”
全部
14,320
临床试验
8,491
药物
238
机构
245
资讯
5,346
2个月前
Genentech Triples Lobbying Spend to $1.81M as Medicare Drug Price Negotiations Intensify
去年
AI Simulations Enhance Clinical Trial Efficiency and Accuracy in Drug Development
去年
Bristol Myers Squibb's Cobenfy Gains Market Advantage After AbbVie's Schizophrenia Drug Fails Trials
去年
Summit Therapeutics' Ivonescimab Shows Promising Results in Lung Cancer Trial, Co-CEO Becomes Billionaire
去年
AI-Designed Drug ISM001-055 Shows Promise in Idiopathic Pulmonary Fibrosis Trial
去年
Recce Pharmaceuticals' Antibiotic R327 Enters Phase 3 Trials Targeting Superbug Infections
去年
NICE Rejects Kisunla for NHS Reimbursement, Citing Cost-Effectiveness Concerns
去年
CMS Access Model Offers Hope for Cell and Gene Therapies in Sickle Cell Disease
去年
CBD Reduces Alcohol Cravings and Brain Reward Center Activity in AUD Patients
去年
Ariceum Therapeutics Presents Promising Data on 225Ac-Satoreotide at EANM 2024
第 1 页,共 535 页
上一页
下一页